Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the list of study locations.
    Difference
    0.0%
    Check dated 2026-04-09T08:01:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added the term Differentiated thyroid carcinoma and a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:22:34.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131. The page revision was updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:31:49.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed revision v3.4.2 from the site's revision history.
    Difference
    0.0%
    Check dated 2026-03-11T10:22:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding status notice and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-11T02:06:37.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, noting that the NIH Clinical Center is open and status updates can be found at opm.gov. The page was updated to revision v3.4.1, replacing the prior v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-03T23:57:09.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.